Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044 [Phase 1, Phase 2]

View source ↗

Summary

The document summarizes safety, tolerability, pharmacokinetics and efficacy findings for the investigational drug YHD1044 in Phase 1 and Phase 2 for premature e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• YHD1044

Snippet

Sponsor: Yuhan Corporation | Conditions: Premature Ejaculation | Phase 1, Phase 2 | Status: COMPLETED